- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.12. | NanoVibronix feeds into new focus on ENvue enteral system with rebrand | ||
| 12.12. | GSK gains FDA expansion for Blujepa to treat gonorrhea | ||
| 12.12. | Amgen's Uplizna breaks into crowded myasthenia gravis market with FDA nod | ||
| 12.12. | Fierce Pharma Asia-Pfizer, Zealand metabolic disease deals; China's 1st private insurance formulary | ||
| 11.12. | European legislators reach agreement on sweeping overhaul to pharma policies | ||
| 11.12. | Geron to lay off third of workforce in bid to slash operating costs | ||
| 11.12. | Abbott teams up with Serena Williams again in Lingo CGM push | ||
| 11.12. | Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx | ||
| 11.12. | Pfizer's cost-cutting drive reaches Switzerland, where company plans to lay off hundreds by year-end: Bloomberg | ||
| 10.12. | FTC claims a win as Teva moves to delist hundreds of patents from FDA Orange Book, agency says | ||
| 10.12. | CDMO Adare plots 137 layoffs in Philly shortly after transplanting headquarters from N.J. | ||
| 10.12. | AstraZeneca-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study | ||
| 10.12. | FDA awards 1st national priority nod to USAntibiotics' Augmentin XR | ||
| 10.12. | In win for pharma, UK cuts medicine rebate rate following US intervention | ||
| 10.12. | FDA finalizes guidance on promotional materials for biologics and biosimilars | ||
| 10.12. | Italian nonprofit lands FDA approval for first gene therapy to treat rare genetic disease | ||
| 10.12. | After deal spree, Supreme Group unites agencies to form new PR and communications group | ||
| 09.12. | CDMOs Bora, Corealis link up to provide one-stop shop for oral solid dose production, development | ||
| 09.12. | Genentech uncovers 'Hidden GeMS' in latest iteration of multiple sclerosis visibility drive | ||
| 09.12. | Roll Tide: Lilly selects Alabama site as location for $6B API facility | ||
| 09.12. | Biocon buys out Viatris and others from biosimilar subsidiary | ||
| 09.12. | FDA now has Merck, AstraZeneca and Sanofi RSV shots for infants in its crosshairs: Reuters | ||
| 09.12. | Biosecure legislation makes way into key US defense bill, teeing up potential China biopharma constraints in '26 | ||
| 09.12. | With eye on AI, Imre hires Nadine Lafond from Ogilvy Health to fill CEO vacancy | ||
| 09.12. | Its future still in limbo, CSL Seqirus debuts $1B flu shot, antivenom plant in Australia |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .